Session 1:
Chairs: Prof Carsten Finke, Charite – Universitatsmedizin Berlin, Germany. Dr James Sejvar, University of Pittsburgh, USA
9:05 KEYNOTE LECTURE 1
Functional Effects of Antibodies in Infectious and Autoimmune Encephalitis
Dr Marianna Spatola IDIBAPS Research Institute, University of Barcelona and La Caixa Research Institute, Barcelona, Spain; Hospital of Sion, Switzerland
9:30 Discussion
9:35 DPPX autoantibodies reduce A-type potassium currents and increase excitability in hippocampal neurons
Dr Sarah Crisp, University of Cambridge, UK
9:45 Discussion
9:50 An international validation of the SEIZURE score for predicting acute seizure risk in encephalitis
Dr Thomas Hughes, University of Liverpool, UK
10:00 Discussion
10:05 Brain atrophy in patients with anti-NMDA receptor encephalitis
Ms Hannah Tenenbaum, Charite – Universitatsmedizin Berlin, Germany
10:15 Discussion
10:20 Validation of the encephalitis criteria in patients with a suspected central nervous system infection: an updated score
Dr Steven L. Staal, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
10:30 Discussion
10:35 Psychiatric manifestations of encephalitis
Dr Ralph Habis, Johns Hopkins University School of Medicine, USA
10:45 Discussion
10:50 TEA/COFFEE/POSTER VIEWING
Session 2:
Chairs: Dr Nicholas Davies, Chelsea and Westminster, Charing Cross, and the Royal Marsden Hospitals, London, UK. Prof Arun Venkatesan, Johns Hopkins University School of Medicine, USA
11:10 Early corticosteroid treatment appears to improve the outcome of HSV encephalitis
Professor Tom Solomon, CBE, The Pandemic Institute; National Institute for Health and Care Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK
11:20 Discussion
11:25 Glycine-receptor antibody mediated CNS effects in vivo: a preliminary study
Dr Manoj Upadhya, Institute of Health and Neurodevelopment, Aston University, UK
11:35 Discussion
11:40 Microbiological investigations for chikungunya virus in children with acute encephalitis syndrome in a non-outbreak setting in Southern India
Ms Maria Jose, National Institute of Mental Health and Neurosciences(NIMHANS), Bengaluru, Karnataka, India
11:50 Discussion
11:55 Investigating T cell immunity in anti-NMDA receptor encephalitis
Dr Rachel Brown, University College London, UK
12:05 Discussion
12:10 Clinical outcomes of adults with suspected encephalitis and meningitis in a high HIV prevalence setting, Blantyre, Malawi
Dr Lerato Mambulu, Kamuzu Central Hospital, Malawi
12:20 Discussion
12:25 INVITED GUEST LECTURE 1
Brains on Fire: Patient Outcomes and Quality of Life Following Encephalitis
Dr Ava Easton, Encephalitis International &University of Liverpool
12:50 Discussion
12:55 LUNCH
Session 3
Chairs: Dr Matteo Gastaldi, Neuroimmunology Research Unit & Diagnostic Laboratory, Pavia, Italy. Assoc Prof Kiran Thakur, Columbia University Irving Medical Center, USA
14:10 KEYNOTE LECTURE 2
Metagenomics, Encephalitis and Global Health
Prof Michael Wilson, UCSF Weill Institute for Neurosciences; Director, UCSF Center for Encephalitis and Meningitis, San Francisco, USA
14:35 Discussion
14:40 Money talks: the cost of encephalitis
Dr Thomas Agerbo Gaist, Odense University Hospital, Denmark
14:50 Discussion
14:55: Encephalitis International Seed Funding
Differentiating viral encephalitis from its mimics in patients with encephalitis of unknown aetiology
Dr John Kasibante, Makerere University, Kampala, Uganda
Validation of the Pediatric Autoimmune Encephalitis Severity Score (PASS) in children with autoimmune encephalitis
Assoc Prof Priyanka Madaan Amrita Institute of Medical Sciences, Faridabad Haryana, India
15:10 Discussion
15:15 BREAK
Session 4:
Chairs: Dr Ava Easton, Encephalitis International & University of Liverpool, UK. Prof Benedict Michael, University of Liverpool & The Walton Center, Liverpool, UK
15:45 Initial findings of the SAPIENCE project: insights from caregivers
Dr Ole Jonas Boeken, Charite – Universitatsmedizin Berlin, Germany
15:55 Discussion
16:00 DEBATE
Encephalitis Research Fails to Improve Diagnosis and Treatment in Low-to-Middle Income Countries (LMIC)
Chair: Assoc Prof Deanna Saylor, Johns Hopkins University School of Medicine, USA & University Teaching Hospital and the University of Zambia School of Medicine, Lusaka, Zambia
Dr Mashina Chomba, University Teaching Hospital – Adult Hospital, Lusaka, Zambia
Prof Gagandeep Singh, Dayanand Medical College Ludhiana, India
16:30 INVITED GUEST LECTURE 2
Improving Diagnosis and Management of People with Brain Infections in Brazil, India and Malawi
Dr Bhagteshwar Singh, University of Liverpool & Royal Liverpool University Hospital, UK
16:55 Discussion
17:00 Encephalitis International: Our Year
Phillippa Chapman, Encephalitis International
17:05 Awards and call to action
Dr Nicholas Davies, Chair Advisory Scientific Panel, Encephalitis International. Dr Ava Easton, CEO Encephalitis International
17:15 DRINKS AND NETWORKING RECEPTION